ChiCTR1800014442.

Trial name or title	Prospective study of the efficacy and safety of improved Italy scheme therapy for IgA nephropathy
Methods	Not reported
Participants	Setting: not yet available Country: China Patients with IgAN; histological diagnosis of IgA; nephropathy with immunofluorescence showing mesangial IgA deposits; age between 15 and 75 years; urinary protein excretion of 0.5 to 3.5 g/day; SCr ≤ 171 mol/L (2 mg/dL) Number: not yet available Mean age ± SD (years): not yet available Sex (M/F): not yet available Exclusion criteria: not yet available
Interventions	Treatment group 1 Methylprednisolone Treatment group 2 Methylprednisolone with low dose oral glucocorticoids
Outcomes	24 hours urinary protein eGFR Clearance creatinine Albumin Triglycerides and cholesterol Fasting plasma glucose Uric acid; blood routine test Routine urine
Starting date	Not reported
Contact information	Li Y: Telephon number and email were not reported
Notes	Estimated study completion date: not reported No study results available